XTalks

JANUARY 14, 2021

The EFSA’s decision is the first step in heralding in EU-wide approval of snacks and other foods containing the insect as an ingredient. A handful of EU countries, including Finland, Belgium and the Netherlands, do already permit the sale of insect-containing products. But that could all change with EFSA’s recent ruling.

Allergies 97

Allergies Protein Containment Sales 97

XTalks

JULY 15, 2021

Not all winemakers mention whether a wine is vegan because there is no regulation that says to include which fining agents were used. Million to Help Parents Fight the Food Allergy Epidemic. In the EU , wines that include milk or egg must be disclosed because they are allergens, but other agents do not. Related: Ready, Set, Food!

Protein 98

Protein Allergies Containment Branding 98

XTalks

AUGUST 30, 2023

Related: Nestlé to Sell Palforzia Peanut Allergy Treatment Products for Lactose Intolerance on the Market The market has witnessed a slew of products aimed at providing relief to the lactose-intolerant population. These range from lactose-free milks and cheeses to lactase tablets that can be consumed before a meal.

Production 52

Production Branding Containment Marketing 52

The Pharma Data

MAY 15, 2021

One French scientists concluded that this ingredient contains something which stimulates the growth of cancerous tumors! Page 61 – This beverage is allowed to contain a drop of white pus (dead blood cells) by the FDA, and has been linked to asthma, allergies, diabetes, heart disease, colitis, Crohns disease and other deadly diseases.

Doctors 52

Doctors Doctor Containment Allergies 52

The Pharma Data

APRIL 3, 2021

The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints.

Clinical Trials 52

Clinical Trials Clinical Trials Medicine Trials 52

The Pharma Data

JANUARY 12, 2021

Virology, Respiratory, Dermatology, Allergy, & Rheumatology) in early & late stage Clinical Development and in Medical Affairs, with a strong track record for Developing and Accelerating Phase I–IV programs. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014.

Life Science 52

Life Science Antibody In-Vivo In-Vitro 52

FDA Law Blog

APRIL 26, 2021

On Friday April 23, President Biden signed into law the Food Allergy Safety, Treatment, Education and Research (FASTER) Act that designates sesame as the ninth major food allergen. By Karin F.R. Moore & Riëtte van Laack —. Then in 2019 Illinois enacted a law that required sesame allergen labeling.

Allergies 98

Allergies Cosmetics Containment Regulation 98

XTalks

MARCH 1, 2021

The regulator used to require that innovator pharmas provide efficacy data on reducing both signs and symptoms of dry eye in the same clinical trial, but this proved to be challenging. Though they both contain the same active ingredient, Cequa is an aqueous solution that contains a higher concentration of cyclosporin compared to Restasis.

Sales 119

Sales Drugs Life Science Containment 119

The Pharma Data

DECEMBER 2, 2020

Having beat the United States to emergency approval of a coronavirus vaccine may pressure American regulators, who are already taking heat for not moving faster to get doses to people, The New York Times reported. GPS sensors will allow the company to track each shipment and ensure it stays cold, the company added.

Vaccination 40

Vaccination Vaccine Nurses Containment 40

FDA Law Blog

APRIL 26, 2021

Moore & Riëtte van Laack — On Friday April 23, President Biden signed into law the Food Allergy Safety, Treatment, Education and Research (FASTER) Act that designates sesame as the ninth major food allergen. By Karin F.R. Then in 2019 Illinois enacted a law that required sesame allergen labeling.

Allergies 40

Allergies Cosmetics Containment Regulation 40

Pfizer

JANUARY 27, 2023

In a limited number of cases when a full virus does not contain any known gain of function mutations, such virus may be engineered to enable the assessment of antiviral activity in cells. and global regulators for all antiviral products and are carried out by many companies and academic institutions in the U.S. and around the world.

Research 112

Research Vaccination Vaccine Drugs 112

The Pharma Data

MAY 13, 2021

FACT: Food labels are NOT required to fully disclose the amounts of certain ingredients contained within foods you consume. Other side effects include food allergy symptoms, increased toxicity, negative reproductive effects, negative effects to digestive systems, unknown genetic effects on humans and EVEN DEATH (rats and mice).

Production 52

Production Containment Genetics Doctors 52

The Pharma Data

NOVEMBER 9, 2020

Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. Furthermore, Amgen’s research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities.

Trials 52

Trials Production Sales Manufacturing 52

The Pharma Data

SEPTEMBER 23, 2020

As the world’s largest healthcare company, we are bringing to bear our best scientific minds, and rigorous standards of safety, in collaboration with regulators, to accelerate the fight against this pandemic. Learn more at www.janssen.com. Follow us at @JanssenGlobal.

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

The Pharma Data

DECEMBER 21, 2020

Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. Furthermore, Amgen’s research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities.

Trials 40

Trials Production Sales Manufacturing 40

The Pharma Data

NOVEMBER 4, 2020

Securities and Exchange Commission Regulation G. It is not known whether patients with allergies to fish and/or shellfish are at an increased risk of an allergic reaction to VASCEPA. Patients with such allergies should discontinue VASCEPA if any reactions occur. Use of Non-GAAP Adjusted Financial Information.

Sales 40

Sales Production Cardiology Marketing 40

XTalks

AUGUST 2, 2023

It contains the antiviral medications nirmatrelvir and ritonavir. In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. It also has a significant presence in consumer health sectors such as dermatology, nutritionals and allergy.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

OCTOBER 28, 2020

Discussions with global regulators are ongoing. Lilly scientists rapidly developed the antibody in less than three months after it was discovered by AbCellera and the scientists at the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center. patients who recovered from COVID-19. . www.lilly.com?and?www.lilly.com/news.?P-LLY.

Antibody 40

Antibody Medicine Manufacturing Scientist 40

The Pharma Data

SEPTEMBER 23, 2020

“As the world’s largest healthcare company, we are bringing to bear our best scientific minds, and rigorous standards of safety, in collaboration with regulators, to accelerate the fight against this pandemic. Learn more at www.janssen.com. Follow us at @JanssenGlobal. Notice to Investors Concerning Forward-Looking Statements.

Clinical Trials 40

Clinical Trials Clinical Trials Vaccination Vaccine 40

The Pharma Data

JANUARY 4, 2021

The authorization is given according to Regulation 29 (A)(9): Medical product designated for pharmaceutical treatment of local citizens in case of epidemic or contagious disease or protection from chemical or radioactive substances, according to Regulation 29 of the Pharmacists’ Regulations (Medical preparations) – 1986.

Vaccination 52

Vaccination Vaccine Medicine Containment 52

The Pharma Data

NOVEMBER 9, 2020

Lilly is in discussions with global regulators to make bamlanivimab available around the world. Lilly scientists rapidly developed the antibody in less than three months after it was discovered by AbCellera and the scientists at the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center. www.lilly.com?and?www.lilly.com/news.?P-LLY.

Antibody 52

Antibody Medicine Manufacturing Trials 52

The Pharma Data

MAY 13, 2021

The early access clinical program plans to administer the vaccine to up to 200,000 individuals beginning with health workers, other frontline workers and others at increased risk of exposure to the Ebola virus (adults and adolescents 14 years and above on a case-by-case basis or depending on national regulations). Follow us at @JanssenGlobal.

Vaccination 52

Vaccination Vaccine Medicine Clinical Trials 52

The Pharma Data

JANUARY 29, 2021

HHSO100201700018C, and in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) at the U.S. Department of Health and Human Services (HHS). Please dial (877) 869-3847 in the U.S. and (201) 689-8261 outside of the U.S.

Vaccination 40

Vaccination Vaccine Trials Immune Response 40

XTalks

SEPTEMBER 14, 2020

“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. These companies include Moderna, a US biotech company which has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID), Oxford University who has partnered with AstraZeneca, and Johnson & Johnson, Merck and Pfizer.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92